Irtra irbesartan/trichloromethiazide regulatory update

Shionogi said Japan approved Irtra irbesartan/trichloromethiazide to treat hypertension. The pharma said it plans to launch Irtra "soon" after National Health Insurance (NHI) listing. The product is a...